Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin
- 223 Downloads
N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) is the enzyme that removes sulfate groups from the N-acetylgalactosamine-4-sulfate residue at the non-reducing end of chondroitin-4-sulfate (C4S) and dermatan sulfate (DS). Previous studies demonstrated reduction in cell-bound high molecular weight kininogen in normal rat kidney (NRK) epithelial cells when chondroitin-4-sulfate content was reduced following overexpression of ARSB activity, and chondroitinase ABC produced similar decline in cell-bound kininogen. Reduction in the cell-bound kininogen was associated with increase in secreted bradykinin. In this report, we extend the in vitro findings to in vivo models, and present findings in Dahl salt-sensitive (SS) rats exposed to high (SSH) and low salt (SSL) diets. In the renal tissue of the SSH rats, ARSB activity was significantly less than in the SSL rats, and chondroitin-4-sulfate and total sulfated glycosaminoglycan content were significantly greater. Disaccharide analysis confirmed marked increase in C4S disaccharides in the renal tissue of the SSH rats. In contrast, unsulfated, hyaluronan-derived disaccharides were increased in the rats on the low salt diet. In the SSH rats, with lower ARSB activity and higher C4S levels, cell-bound, high-molecular weight kininogen was greater and urinary bradykinin was lower. ARSB activity in renal tissue and NRK cells declined when exogenous chloride concentration was increased in vitro. The impact of high chloride exposure in vivo on ARSB, chondroitin-4-sulfation, and C4S-kininogen binding provides a mechanism that links dietary salt intake with bradykinin secretion and may be a factor in blood pressure regulation.
KeywordsBradykinin Chondroitin Disaccharide Kininogen Sulfatase Sulfate
The authors thank Robert Chanthimabha for his help with determinations of creatinine and electrolytes. Research was supported by VA Merit Awards to R.S. Danziger, M.D. and J.K. Tobacman, M.D. and NIDDK R21HL096031 to Dr. Danziger.
- 1.De Sousa, J.F., Nader, H.B., Dietrich, C.P.: Sequential degradation of chondroitin sulfate in mollusks. J. Biol. Chem. 265, 20150–20155 (1990)Google Scholar
- 2.Glaser, J.H., Conrad, H.E.: Chondroitin SO4 catabolism in chick embryo chondrocytes. J. Biol. Chem. 254, 2316–2325 (1978)Google Scholar
- 5.Gozzo, A.J., Nunes, V.A., Carmona, A.K., Nader, H.B., von Dietrich, C.P., Silveira, V.L.F., Shimamoto, K., Ura, N., Sampaio, M.U., Sampaio, C.A.M., Araujo, M.S.: Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation. Int. Immunopharmacol. 2, 1861–1865 (2002)Google Scholar
- 9.Sharma G, Burke J, Bhattacharyya S, Sharma N, Katyal S, Park RL, Tobacman J: Reduced arylsulfatase B activity in leukocytes from cystic fibrosis patients. Pediatr. Pulmonol. (2012). doi: 10.1002/ppul.22567
- 19.Yang, B., Weyers, A., Baik, J.Y., Sterner, E., Sharfstein, S., Mousa, S.A., Zhang, F., Dordick, J.S., Linhardt, R.J.: Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis. Anal. Biochem. 314, 59–66 (2011)CrossRefGoogle Scholar
- 26.Bilusic, M., Bataillard, A., Tschannen, M.R., Gao, L., Barreto, N.E., Vincent, M., Wang, T., Jacob, H.J., Sassard, J., Kwitek, A.E.: Mapping the genetic determinants of hypertension, metabolic diseases, and related phenotypes in the Lyon hypertensive rat. Hypertension 44, 695–701 (2004)PubMedCrossRefGoogle Scholar
- 34.Batlle, D., Redon, J., Gutterman, C., LaPointe, M., Saleh, A., Sharma, A., Rombola, G., Ye, M., Alsheikha, W., Gomez, L., Sobrero, M.: Acid–base status and intracellular pH regulation in lymphocytes from rats with genetic hypertension. J. Am. Soc. Nephrol. 5(5Suppl 1), S12–S22 (1994)PubMedGoogle Scholar
- 35.Cuthbert, A.W.: New horizons in the treatment of cystic fibrosis: Br. J. Pharmacol. 163(1), 173–183 (2011)Google Scholar